An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics and Safety of DWJ1392 and DWC20164 in Healthy Male Volunteers

Trial Profile

An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics and Safety of DWJ1392 and DWC20164 in Healthy Male Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs DWC 20164 (Primary) ; DWJ 1392 (Primary)
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Daewoong Pharmaceutical
  • Most Recent Events

    • 13 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top